Viewing nowCombinationTrinam 5/1000 mg Extended-Release Tablet (Linagliptin, Metformin)
Linagliptin Besylate 6.67mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.

MFDS item code 202401579 · Approved 2024.06.28 · Insurance code 694004290
Improvement of glycemic control in type 2 diabetes mellitus
This medication helps in the control of blood sugar levels in patients with type 2 diabetes by combining linagliptin and metformin. It is administered as an adjunct to dietary and exercise therapy, enabling effective management of blood glucose levels. This helps improve blood sugar control and assists in the management of diabetes.
In antidiabetic therapy, the dose of this drug should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily dose of each component: 5mg of linagliptin (6.67mg of linagliptin besylate) and 2000 mg of extended-release metformin hydrochloride. This drug should be taken once daily with a meal, with the evening meal. Take 1 tablet of this drug 5/1000 mg extended-release tablet once daily. Patients taking this drug 2.5/1000 mg extended-release tablet should take 2 tablets at the same time, once daily. 1. Patients not currently receiving metformin therapy: The initial dose of this drug is a total daily dose of linagliptin 5 mg and metformin hydrochloride 1000mg. The dose of metformin hydrochloride may be gradually increased up to the maximum recommended daily dose of 2000 mg. 2. Patients receiving metformin therapy - For patients who cannot achieve adequate glycemic control with metformin monotherapy, the initial dose of this drug is a total daily dose of linagliptin 5 mg and the patient's current dose of metformin hydrochloride. - For patients who cannot achieve adequate glycemic control with combination therapy of metformin and a sulfonylurea, or metformin and insulin, an initial dose of this drug consisting of a total daily dose of linagliptin 5mg and a dose of metformin hydrochloride similar to the patient's current dose should be considered. - When switching from an immediate-release metformin formulation to an extended-release formulation, glycemic control should be closely monitored and dosage adjustments made as appropriate, if necessary. - When switching from combination therapy with linagliptin and extended-release metformin to this drug, the dose of this drug should be the patient's current dose of linagliptin and extended-release metformin hydrochloride. No dose adjustment of this drug is necessary in patients with mild renal impairment [creatinine clearance (CrCl) ≧ 60mL/min or estimated glomerular filtration rate (eGFR) ≧ 60mL/min/1.73 m2]. In patients with moderate renal impairment (CKD stage 3A), defined as creatinine clearance (CrCl) of 45mL/min or greater and less than 60mL/min, or estimated glomerular filtration rate (eGFR) of 45mL/min/1.73m2 or greater and less than 60mL/min/1.73m2, this drug may be used with an adjustment of the metformin hydrochloride dose as follows, provided it is well tolerated and the patient has no other conditions that may increase the risk of lactic acidosis. The starting dose of metformin hydrochloride is 500mg or 750mg once daily; therefore, treatment should not be initiated with this drug. The maximum daily dose of metformin hydrochloride is 1000mg. If creatinine clearance (CrCl) decreases to less than 45mL/min or estimated glomerular filtration rate (eGFR) decreases to less than 45mL/min/1.73m2, this drug should be discontinued immediately.
This drug is used for the treatment of diabetes and helps lower blood sugar. However, it may rarely cause a serious condition called lactic acidosis, warranting caution. It should not be used in patients with poor kidney function, liver dysfunction, or in acute conditions such as acute myocardial infarction or severe infections. Patients with allergies to any component of this drug or those with type 1 diabetes should also avoid its use. There is a risk of hypoglycemia, so blood glucose changes must be carefully monitored when used with insulin or sulfonylureas. In situations where renal function is impaired, temporary discontinuation of this drug may be necessary. Additionally, acute pancreatitis or blistering skin conditions may develop, so consult a physician immediately if symptoms occur. This drug may lower vitamin B12 levels, necessitating regular blood tests during prolonged use. Alcohol consumption can increase the risk of lactic acidosis and should be avoided. Use during pregnancy or breastfeeding should be avoided, and patients planning pregnancy should consult a physician. Elderly patients have a higher risk of kidney function deterioration and require dosage adjustments and regular kidney function tests. In situations that could impact kidney function, such as surgery or radiological examinations, administration of this drug should be temporarily suspended. This medication must be swallowed whole and should not be chewed or crushed. Be aware that there may be drug interactions, so inform your physician or pharmacist of any other medications you are taking. Overdose may cause gastrointestinal disorders or lactic acidosis, requiring immediate medical attention. Store this medication away from children's reach, keep it in a dry place, and store it in the original container.
Severe lactic acidosis, hypoglycemia, nasopharyngitis, hypersensitivity reactions, angioedema, urticaria, lactic acidosis, abnormal vitamin B12 absorption test, hypoglycemic symptoms, taste disturbance, cough, loss of appetite, diarrhea, constipation, nausea, pancreatitis, vomiting, abdominal pain, oral ulcers, abnormal liver function tests, hepatitis, pruritus, erythema, rash, dermatitis herpetiformis, severe and disabling arthralgia, rhabdomyolysis, increased lipase, increased amylase, constipation, upper abdominal pain, enterocolitis, intestinal obstruction, gastritis, herpes zoster, cystitis, acute pyelonephritis, bronchitis, vestibular neuronitis, sepsis, pneumonia, decreased appetite, dehydration, hyperglycemia, cerebral infarction, stuttering, Alzheimer's type dementia, chest pain, fever, facial edema, fatigue, chronic obstructive pulmonary disease, asthma, diabetic foot disease, skin lesions, liver metastasis, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, stomach cancer, rectal cancer, pancreatic cancer, meniscus injury, pneumoconiosis, congestive heart failure, angina pectoris, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, dizziness, renal transplant failure, pneumonia, hypercholesterolemia, headache, drowsiness, chest discomfort, asthenia, epistaxis, oropharyngeal pain, speech disorders, allergic rhinitis, exercise-induced dyspnea, wet cough, nasal discharge, pulmonary mass, arthralgia, osteoporosis, arthropathy, musculoskeletal discomfort, myositis, myalgia, soft tissue mass, rotator cuff syndrome, increased serum triglycerides, decreased hemoglobin, increased serum potassium, increased serum creatinine, increased serum creatine phosphokinase activity, increased ALT, male pattern baldness, hyperhidrosis, hair loss, dermatitis, anxiety, mood disorders, insomnia, depression, bruising, bone bruising, concussion, bone fracture, hand fracture, diabetic neuropathy, sensory disturbances, post-herpetic neuralgia, partial paralysis, syncope, confusional state, nocturia, vascular disorders, hypotension, flushing, hepatic steatosis, cholelithiasis, hearing loss, erectile dysfunction, goiter, anemia, nausea, gastroesophageal reflux disease, gastritis, stomatitis, dyspepsia, anal bleeding, cheilitis, dental caries, enteritis, gastric ulcer, gum bleeding, hemorrhoids, lower abdominal pain, dysphagia, vitreous hemorrhage, fever, ligament sprain, flank pain, myelodysplastic syndrome, vocal cord polyp, pruritus, hypertension, benign prostatic hyperplasia
Not everyone experiences these, and they can vary from person to person.
This drug is sensitive to air and moisture; therefore, it should be stored in a sealed container. It is crucial to maintain a storage temperature between 1 and 30 degrees Celsius. This helps ensure the drug's effectiveness is safely preserved for an extended period.
This drug is a yellow oval-shaped extended-release film-coated tablet.
30 tablets/bottle, 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLinagliptin Besylate 6.67mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationLinagliptin Besylate 3.34mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationLinagliptin Besylate 3.34mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationLinagliptin Besylate 3.34mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationLinagliptin Besylate 3.34mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
DaiWoong Bio Co., Ltd.
CombinationLinagliptin Besylate 3.34mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationLinagliptin Besylate 3.34mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationLinagliptin Besylate 3.34mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.